Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
about
Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic reviewWhen Prostate Cancer Circulates in the BloodstreamNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismPrognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant NeoplasmsNovel RNA markers in prostate cancer: functional considerations and clinical translationCirculating microRNAs: potential biomarkers for common malignanciesElevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohortMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesSystemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction.MicroRNAs in the control of metastatic bone disease.Noncoding RNAs as novel biomarkers in prostate cancer.Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy.Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance.MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling.MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcriptionA Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate CancerInitial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discoveryIdentification of a circulating microRNA signature to distinguish recurrence in breast cancer patientsSerum microRNA expression patterns that predict early treatment failure in prostate cancer patients.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Regulation of miR-200c and miR-141 by Methylation in Prostate Cancer.Circulating miRNAs as biomarkers for endocrine disorders.Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance.A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells.The role of exosomes and miRNAs in drug-resistance of cancer cells.miRNA in Prostate Cancer: New Prospects for Old ChallengesPrognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
P2860
Q26748872-4823F4B0-6D90-41D0-A470-09FCEC66180EQ26768470-FD0CF732-9D94-417A-BCC4-D77B64ED5455Q26774456-01C78EFD-B33A-4970-9B19-BBB66FBF8DCDQ26778084-038F1596-276C-4462-B875-071A4DE24EEDQ27021174-F40EDD91-938A-412C-A179-985D15E59C46Q28081347-2A53E792-9594-4DCD-A8EB-B9862B4EF30FQ28546311-F2B6F390-5973-4E62-BF21-89622DD457F4Q30859743-08867955-106E-4D89-9DE2-0DF02C6B2C0FQ33677280-69C2EC11-BDE0-47FC-9488-8DD9DA86F71DQ33821326-6ED2E1B5-AC97-428D-9E57-67E55FFCE323Q34176890-0E06E6F7-98E3-4097-B32D-2AEFE152119AQ34381845-2E839046-817F-479F-96FE-087574DAE524Q34735084-7F360584-FFC3-4E30-A537-E59796A987BBQ35023641-28A24E9C-CBA0-4740-BAE8-97EC4AF92A8DQ35126364-0C4FA475-1673-49ED-BB13-F835BA62AF4DQ35180831-E2AEEEC8-53D1-4041-A439-69275DFF49CEQ35510445-D8E8D4F7-15D3-46C0-8596-75C380A82864Q35788900-AE11F040-D8B8-45DA-ACBD-DC8AF95650E6Q35794952-56FE8C02-615F-4A84-B403-E6C529777DA4Q36107831-32B35462-8971-4A79-861C-377A866F6E3EQ36189343-63E0B267-0EEC-47FE-9419-F06B1444B0DDQ36216675-2E69F2DC-96E3-4FFE-BB4C-D4FF58DB10E5Q36407203-A466E334-F04F-4127-A623-A6A0AEA07F09Q36665167-0C58C9C3-36B0-4D40-91FD-D57C1AA24C36Q36695308-73BC9029-9EC3-4CBD-9AF2-5F70053A7EB3Q36939358-A694EA97-BB85-44D2-973B-F1875975682EQ37022401-776491E3-C87D-49EA-AB4D-19C288E93A4DQ37113174-AA292061-1BB1-49F8-B810-24D075393C11Q37688228-BAD8AAF3-111F-491F-90F6-98C4D7D48B90Q37718420-FE03401C-14BB-44DB-8EA3-DD509CFA0404Q38216129-D5B31378-6E79-4861-829B-A946AB64C93BQ38380233-988F9114-DEB2-4384-8D27-171B75A099BEQ38503895-5DD378F3-D66C-4013-B5EC-59B20536C7A8Q38667456-ABB70AF7-763E-41F6-947F-3B6304A1710AQ38681199-2EBE2322-2972-4CB8-8CD8-8F1943C8A938Q38766156-06F16133-17FB-490B-899A-5CC197716770Q38829640-3E246676-7629-4A54-B829-FA085957AAB3Q39152624-532B19EC-E9C9-40B6-A937-8DD4E1B77F09Q39220695-57C8AB46-A0C4-45AA-9FDD-A9AD962475F3Q40574583-D43C91D5-3312-45C4-88F7-43F317D4979D
P2860
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
@en
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
@nl
type
label
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
@en
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
@nl
prefLabel
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
@en
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
@nl
P2093
P2860
P356
P1476
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
@en
P2093
G J Goodall
L G Horvath
L M Butler
P D Stricker
P D Sutherland
S L Townley
W D Tilley
P2860
P2888
P304
P356
10.1038/BJC.2013.369
P407
P577
2013-07-11T00:00:00Z